pharmaphorum

JULY 26, 2022

For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. Preventative vaccines have already proven to be highly effective against certain cancer types. Preventative vaccines have already proven to be highly effective against certain cancer types. And for good reason.

Vaccines 52

Vaccines Immunization 52

Pharmaceutical Technology

MAY 1, 2023

The successful launch of mRNA vaccines during the Covid-19 pandemic has not only spurred mRNA-related research across interdisciplinary groups, but also further validated the use of lipid nanoparticles as delivery approaches.

Vaccines 52

Vaccines 52

Pharma Mirror

NOVEMBER 30, 2020

The new report looks ahead to a post-pandemic 2021 with pharma manufacturing capacity and payment structures shifting as new sourcing strategies emerge Amsterdam: A new report from CPhI explores the potential implications in 2021 of impending vaccine approvals, a new administration in the White House and a return to dual supply chain strategies.

Vaccines 52

Vaccines 52

Pharma Mirror

SEPTEMBER 22, 2021

Nantes, France, Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of viral vaccines BSL2/BSL3, oncolytic viruses and viral vectors, today announces the next phase in its partnership with FluGen, Inc., The company’s.

Vaccines 52

Vaccines 52

Pharma Mirror

MAY 10, 2021

FarmaTrust, the UK-based global medical supply chain data management provider – has warned that the UK is heading very rapidly down the wrong direction with vaccine passports. This is particularly important as the public needs comfort in respect of certification or vaccination apps, and concerns on access to individual’s health data.

Vaccines 52

Vaccines 52

Pharma Mirror

SEPTEMBER 11, 2022

Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Mirror

AUGUST 19, 2020

has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. The post Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

Pharma Mirror

AUGUST 28, 2021

ADELAIDE- Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif.

Vaccines 52

Vaccines 52

Pharma Mirror

SEPTEMBER 30, 2021

SINGAPORE; The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid.

Vaccines 52

Vaccines 52

Pharma Mirror

MAY 23, 2023

QS-21 is used in several innovative vaccines against diseases such as shingles, malaria and RSV, plus promising new vaccine and immunotherapy treatments such as cancer. BSI) partner to fast-track sustainable vaccine adjuvant QS-21 production appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 27, 2023

For vaccines that target infectious diseases, as Pragya Khurana and Dr Richard Pitman of ICON explain, cost-effectiveness research can power evidence generation and decision-making that helps keep people safe. Cost-effectiveness modelling is a powerful tool in understanding the value health interventions can bring to populations.

Vaccines 52

Vaccines 52

Pharma Mirror

APRIL 24, 2022

and NEC Corporation, today announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine. The post Shionogi and NEC Enter into Strategic Research Collaboration for Novel Hepatitis B Therapeutic Vaccine appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

Pharma Mirror

OCTOBER 22, 2021

Considerations for Immuno-oncology and Vaccine Studies and the Bioanalytical Tools used” in partnership with Outsourcing Clinical Trials (OCT). PGCM) said: “Choosing the right bioanalytical platform for your immunology or vaccines clinical trial is critical to data collection. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D,

Vaccines 52

Vaccines 52

Pharma Mirror

FEBRUARY 19, 2022

Although COVID-19 vaccine booster shots have been administered across the globe since 3Q2021, vaccine efficacy is shown to vary among vaccine products, and it is crucial.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 20, 2023

For millions of people around the world living with infectious disease and cancer, the arrival of a new prophylactic or therapeutic vaccine on the market can be life changing. Commercialising a vaccine, even one that targets an unmet need, is a challenging task for companies.

Vaccines 52

Vaccines 52

Pharma Mirror

SEPTEMBER 2, 2020

The post Jacobson Pharma Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of BioNTech SE’s COVID-19 Vaccine Candidate in Hong Kong and Macau appeared first on Pharma Mirror Magazine. a wholly-owned subsidiary of Shanghai.

Vaccines 52

Vaccines 52

Pharma Mirror

FEBRUARY 18, 2021

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16.

Immunization 52

Immunization Vaccines 52

pharmaphorum

JANUARY 21, 2021

While restrictions on travel could prevent coronavirus transmission in the short term, digital passports showing COVID-negative and vaccination status may help reopen airports and other badly hit areas of the economy, reports Richard Staines. But getting the technology to work is taking time.

Vaccines 85

Vaccines Immunization Hospitals 85

Pharma Mirror

APRIL 21, 2024

With the rapid development of biotechnology and molecular medicine, the introduction of mRNA as a vaccine or therapeutic agent enables the production of almost any desired functional protein/peptide within the human body.

Vaccines 52

Vaccines 52

Pharma Mirror

OCTOBER 29, 2021

Pharmacists help their communities and, indeed, the medical industry as a whole by administering vaccinations, making drug recommendations, providing access to medical care in underserved areas, contributing to many different fields in the medical profession, and so much more. Vaccinations You.

Vaccines 52

Vaccines 52

Pharma Mirror

OCTOBER 20, 2020

The post COVID-19 biologics will put huge pressure on large-scale bioprocessing networks appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

Pharma Mirror

DECEMBER 1, 2022

QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications. Botanical Solution Inc. BSI and Croda Pharma are announcing this Partnership Agreement at the World Vaccine and Immunotherapy Congress West Coast 2022 in San Diego this week. It is used.

Vaccines 52

Vaccines 52

Pharma Mirror

APRIL 24, 2022

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.

Vaccines 52

Vaccines 52

Pharma Mirror

JANUARY 23, 2023

This webinar focused on the need for a coordinated clinical trials enterprise, one that can quickly characterize emerging viral threats and evaluate the effectiveness of vaccines, therapeutics, and other countermeasures across a diversity of trial participants.

Vaccines 59

Vaccines 59

Pharma Mirror

DECEMBER 9, 2021

UAE, Abu Dhabi , Abu Dhabi has set its sights on Belgium, as a leading global pharmaceutical hub, to establish a global distribution corridor to serve the world in vaccine delivery and future life science needs. This initiative entailed a delegation visit from Belgium to Abu Dhabi, hosted by the Department of Health – Abu Dhabi (DoH).

Vaccines 52

Vaccines 52

Pharma Mirror

OCTOBER 29, 2021

Petrovax is the largest Russian exporter of original medicines and vaccines; the. The post Petrovax Pharm is taking part in CPhI Worldwide-2021 appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. But Dix has also been leading the UK’s Vaccine Taskforce, after taking over the hot seat in December following the departure of Kate Bingham.

Vaccines 98

Vaccines 98

Pharma Mirror

JANUARY 19, 2024

Inflation and rising material costs cutting into the profits of many life science companies and a continuation of the COVID comedown has left vaccine producers facing challenges and emphasizing the need for diversification of The post Navigating the 2024 Life Science Industry Trends Landscape appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

Pharma Mirror

OCTOBER 16, 2023

The first mRNA drug (BNT162b2 vaccine) was granted emergency use authorization by the FDA in December 2020 and approved for marketing in August 2021. The first mRNA drug (BNT162b2 vaccine) was granted emergency use authorization by the FDA in December 2020 and approved for marketing in August 2021.

Immunization 52

Immunization Vaccines FDA 52

Pharma Mirror

OCTOBER 17, 2022

The CDMO provides recombinant proteins, vaccines, and complex live biotherapeutic products to customers on the leading edge in emerging therapeutics. The post AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program appeared first on Pharma Mirror Magazine. Dr. Haifer stated “These.

Vaccines 52

Vaccines 52

Pharma Mirror

JANUARY 4, 2022

The findings suggest that there will be 30+ FDA new drug approvals in the next year, more than five commercial COVID vaccines – resulting in a production squeeze at CDMOs and consequentially higher margins and profits for supply side companies – with mRNA, advanced therapies.

Vaccines 52

Vaccines FDA 52

Pharma Mirror

MAY 10, 2023

These systems also utilize refrigerant, which limits cooling to approximately -100°C and is known to The post Liquid Nitrogen Freezers Prove to be Game Changer for Pharma Industry appeared first on Pharma Mirror Magazine. Unfortunately, traditional mechanical freezers are limited in significant aspects.

Vaccines 52

Vaccines 52

Pharma Mirror

MARCH 29, 2022

NIEL, BELGIUM, eTheRNA Manufacturing, a specialist RNA process developer and manufacturing member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and early pre-clinical development of RNA-based therapeutics and vaccines.

Vaccines 52

Vaccines 52

Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The post 7 Problems with Using Borosilicate Glass to Package Drugs appeared first on Pharma Mirror Magazine.

Packaging 52

Packaging Vaccines 52

Pharma Mirror

DECEMBER 9, 2021

For example, to meet the urgent need for COVID-19 related therapies and vaccines early in the pandemic, Thermo Fisher Scientific, a world leader in serving science with annual revenue of approximately $35 billion, had to expand its manufacturing capacity quickly and dramatically at its Greenville, North Carolina plant to meet urgent demand.

Vaccines 52

Vaccines 52

Pharma Mirror

JANUARY 26, 2023

Within the region, the Indian market shows impressive success, responsible for 80% of anti-retroviral drugs and 50% of the global supply of vaccines. The APAC market is The post <strong>APAC overview: trends, challenges, and possibilities for growth in the MarTech sector</strong> appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

Pharma Mirror

MARCH 31, 2022

Symbiosis Pharmaceutical Services Ltd (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has announced the completion of a £1.3

Vaccines 52

Vaccines 52